Thyrocare to acquire Vimta Labs’ diagnostic business for ₹7 crore

The shares of Thyrocare Technologies Limited were trading at ₹859.30, down by ₹5.30 or 0.61 per cent on the NSE

Subscribe To Our Free Newsletter